[Federal Register Volume 64, Number 128 (Tuesday, July 6, 1999)]
[Presidential Documents]
[Pages 36549-36557]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-17291]
[[Page 36547]]
_______________________________________________________________________
Part VII
The President
_______________________________________________________________________
Proclamation 7207--To Extend Nondiscriminatory Treatment (Normal Trade
Relations Treatment) to Products of Mongolia and To Implement an
Agreement To Eliminate Tariffs on Certain Pharmaceuticals and Chemical
Intermediates
Presidential Documents
Federal Register / Vol. 64, No. 128 / Tuesday, July 6, 1999 /
Presidential Documents
___________________________________________________________________
Title 3--
The President
[[Page 36549]]
Proclamation 7207 of July 1, 1999
To Extend Nondiscriminatory Treatment (Normal
Trade Relations Treatment) to Products of Mongolia and
To Implement an Agreement To Eliminate Tariffs on
Certain Pharmaceuticals and Chemical Intermediates
By the President of the United States of America
A Proclamation
1. The United States has had in effect a bilateral
Agreement on Trade Relations with Mongolia since 1991
and has provided normal trade relations treatment to
the products of Mongolia since that time. I have found
Mongolia to be in full compliance with the freedom of
emigration requirements of title IV of the Trade Act of
1974 (the ``Trade Act'') (19 U.S.C. 2432).
2. Pursuant to section 2424(b)(1) of Public Law 106-36,
and having due regard for the findings of the Congress
in section 2424(a) of said Law, I hereby determine that
title IV of the Trade Act (19 U.S.C. 2431-2441) should
no longer apply to Mongolia.
3. On November 13, 1998, members of the World Trade
Organization (WTO), including the United States and 21
other major trading countries, announced in the WTO an
agreement to eliminate tariffs on certain
pharmaceuticals and chemical intermediates that were
the subject of reciprocal duty elimination negotiations
during the Uruguay Round of Multilateral Trade
Negotiations (the ``Uruguay Round''). A similar
agreement between the United States and 16 other major
trading countries eliminating tariffs on enumerated
pharmaceuticals and chemical intermediates was
implemented for the United States on April 1, 1997, by
Proclamation 6982, adding such goods to the scope of
the agreement on pharmaceutical products reached at the
conclusion of the Uruguay Round and reflected in
Schedule XX-United States of America, annexed to the
Marrakesh Protocol to the General Agreement on Tariffs
and Trade (1994) (Schedule XX).
4. Section 111(b) of the Uruguay Round Agreements Act
(URAA) (19 U.S.C. 3521(b)) authorizes the President to
proclaim the modification of any duty or staged rate
reduction of any duty set forth in Schedule XX for
products that were the subject of reciprocal duty
elimination negotiations during the Uruguay Round, if
the United States agrees to such action in a
multilateral negotiation under the auspices of the WTO,
and after compliance with the consultation and layover
requirements of section 115 of the URAA (19 U.S.C.
3524). Section 111(b) also authorizes the President to
proclaim such modifications as are necessary to reflect
such duty treatment in Schedule XX by means of
rectifications thereof.
5. On April 29, 1999, pursuant to section 115 of the
URAA, the United States Trade Representative (USTR)
submitted a report to the Committee on Ways and Means
of the House of Representatives and the Committee on
Finance of the Senate (``the Committees'') that sets
forth the proposed tariff eliminations, together with
the advice received from the appropriate private sector
advisory committee and the United States International
Trade Commission regarding the proposed tariff
eliminations. During the 60-day period thereafter, the
USTR consulted with the Committees on the proposed
actions.
[[Page 36550]]
6. Section 604 of the Trade Act, as amended (19 U.S.C.
2483), authorizes the President to embody in the
Harmonized Tariff Schedule of the United States (HTS)
the substance of the relevant provisions of that Act,
and of other acts affecting import treatment, and
actions thereunder, including the removal,
modification, continuance, or imposition of any rate of
duty or other import restriction.
7. Pursuant to section 111(b) of the URAA, I have
determined that Schedule XX should be modified to
reflect the implementation by the United States of the
multilateral agreement on certain pharmaceuticals and
chemical intermediates negotiated under the auspices of
the WTO. In addition, I have determined that the
pharmaceuticals appendix to the HTS should be modified
to reflect the duty eliminations provided in such
agreement, and to make certain minor technical
corrections in the identification of particular
products in order to ensure that products are accorded
the intended duty treatment.
NOW, THEREFORE, I, WILLIAM J. CLINTON, President of the
United States of America, acting under the authority
vested in me by the Constitution and the laws of the
United States, including but not limited to section
2424(b)(2) of Public Law 106-36, section 111(b) of the
URAA, and section 604 of the Trade Act, do hereby
proclaim that:
(1) Nondiscriminatory treatment (normal trade
relations treatment) shall be extended to the products
of Mongolia, which shall no longer be subject to title
IV of the Trade Act.
(2) The extension of nondiscriminatory treatment to
the products of Mongolia shall be effective as of the
date of signature of this proclamation.
(3) In order to implement the multilateral
agreement negotiated under the auspices of the WTO to
eliminate tariffs on certain pharmaceutical products
and chemical intermediates, and to make technical
corrections in the tariff treatment accorded to such
products, the HTS is modified as set forth in the Annex
to this proclamation.
(4) Such modifications to the HTS shall be
effective with respect to articles entered, or
withdrawn from warehouse for consumption, on or after
the dates set forth in the Annex for the respective
actions taken.
(5) Any provisions of previous proclamations and
Executive orders that are inconsistent with the actions
taken in this proclamation are superseded to the extent
of such inconsistency.
IN WITNESS WHEREOF, I have hereunto set my hand this
first day of July, in the year of our Lord nineteen
hundred and ninety-nine, and of the Independence of the
United States of America the two hundred and twenty-
third.
(Presidential Sig.)
Billing code 3195-01-P
[[Page 36551]]
[GRAPHIC] [TIFF OMITTED] TD06JY99.018
[[Page 36552]]
[GRAPHIC] [TIFF OMITTED] TD06JY99.019
[[Page 36553]]
[GRAPHIC] [TIFF OMITTED] TD06JY99.020
[[Page 36554]]
[GRAPHIC] [TIFF OMITTED] TD06JY99.021
[[Page 36555]]
[GRAPHIC] [TIFF OMITTED] TD06JY99.022
[[Page 36556]]
[GRAPHIC] [TIFF OMITTED] TD06JY99.023
[[Page 36557]]
[GRAPHIC] [TIFF OMITTED] TD06JY99.024
[FR Doc. 99-17291
Filed 7-2-99; 11:02 am]
Billing code 3190-01-C
